SAN FRANCISCO — Delayed ophthalmic care may contribute to an increased risk for certain types of psychosis. In analysis of nearly 121,000 older patients with glaucoma, those who received delayed eye care had significantly greater risk for the development ... See more
SAN FRANCISCO — Luvesilocin, a novel psychedelic 5-hydroxytryptamine receptor 2A (5HT2A) agonist compound formerly known as RE104, was associated with fast and durable improvement in women with moderate-to-severe postpartum depression (PPD). This was the ... See more
SAN FRANCISCO — Une nouvelle étude suggère que la fluoxétine, un inhibiteur sélectif de la recapture de la sérotonine (ISRS), et le bupropion, un inhibiteur de la recapture de la noradrénaline et de la dopamine (IRND), sont tous deux efficaces pour traite... See more
SAN FRANCISCO. Una nueva investigación ha revelado que un mayor consumo de cafeína se asoció con síntomas depresivos más graves en general, pero también pareció atenuar la relación entre la depresión y el insomnio grave y el estrés. En un análisis transve... See more
SAN FRANCISCO — Curcumin supplements, which contain the primary active compound in the spice turmeric, may help reduce depressive symptoms when used alongside standard treatment for clinical depression. A meta-analysis of randomized controlled trials show... See more
